Rx
Chat
Home
›
Drugs: T
›
Truqap
Truqap
Active Ingredient(s):
Capivasertib
FDA Approved: *
November 16, 2023
Pharm Company: *
ASTRAZENECA PHARMS
Category:
Cancer
* May have multiple approval dates, manufacturers, or labelers.
Start a Discussion
Dosage List
Truqap 160 mg Oral Tablet, Film Coated
NDC:
0310-9500
Labeler:
Astrazeneca Pharmaceuticals Lp
Truqap 200 mg Oral Tablet, Film Coated
NDC:
0310-9501
Labeler:
Astrazeneca Pharmaceuticals Lp
COMMUNITY
Home Page
Drug Forums
Submit a Topic
Health Newsletter
DRUGS
Top Prescription Drugs
Drug Categories
NDC Database
Half Life Calculator
Recent FDA Approvals
ABOUT
Medical Disclaimer
Terms of Use
Privacy Policy
Cookie Manager
Do Not Sell or Share My
Personal Information
DRUG INDEX
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
This website is intended for informational purposes only. It is not meant to be a substitute for medical advice from a healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer.
Copyright © 2005-2024 RxChat.com. All Rights Reserved.
RxChat.com
9878 W Belleview Ave #5000
Denver, CO 80123
United States